Chester County News and Community Website
PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. announced it will present interim clinical data from its first-in-human Phase 1 study of VIPER-101, a CD5-modulated autologous CAR-T therapy, at the upcoming American …
New CAR-T Data Could Upend T-Cell Lymphoma Care — Vittoria Prepares First Reveal Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced that a newly published clinical case study has demonstrated the successful use of its 308-nanometer excimer laser in treating a …
STRATA Skin Sciences Excimer Laser Shown Effective in Treating Rare Form of Skin Lymphoma Read More PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. has announced the launch of its Phase 1 clinical trial for VIPER-101, a cutting-edge gene-edited cell therapy aimed at treating relapsed and refractory (r/r) T …
Vittoria Biotherapeutics Launches Trial for Innovative T Cell Lymphoma Therapy Read More